Patent · US Active

Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors

US8791118B2 · kind B2 · utility

0Cited by

2References

10Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Matthias Gerlach · Wächtersbach, DE
Irene Seipelt · Offenbach, DE
Lars Blumenstein · Frankfurt am Main, DE
Gilbert Mueller · Frankfurt am Main, DE
Eckhard Guenther · Maintal, DE
Tilmann Schuster · Großostheim, DE
Michael Teifel · Weiterstadt, DE

Key dates

Filing date	Apr 4, 2012
Grant date	Jul 29, 2014
Priority date	—
Expiry date	May 22, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides new pyridopyrazine compounds according to formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.